A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)
Completed · Phase 2 · Has a placebo group
Conditions studied: NASH - Nonalcoholic Steatohepatitis
In brief
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study administered for 16 weeks in subjects with biopsy proven F1 - F4 NASH.
Key facts
- Study ID
- NCT03976401
- Run by
- Akero Therapeutics, Inc
- People needed
- 110
- Starts
- 2019-05-28
- Expected to finish
- 2022-01-10
- Last updated by the study team
- 2022-08-04
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Weight gain or loss > 5% in the 3 months prior to randomization or > 10% in the 6 months prior to screening.
- Type 1 and insulin-dependent Type 2 diabetes.
- Poorly controlled hypertension (blood pressure > 160/100).
Where it is running
- Akero Clinical Study Site — Tucson, Arizona, United States
- Akero Clinical Study Site — Little Rock, Arkansas, United States
- Akero Clinical Study Site — Huntington Park, California, United States
- Akero Clinical Study Site — Los Angeles, California, United States
- Akero Clinical Study Site — Los Angeles, California, United States
- Akero Clinical Study Site — Panorama City, California, United States
- Akero Clinical Study Site — Poway, California, United States
- Akero Clinical Study Site — Boca Raton, Florida, United States
- Akero Clinical Study Site — Lakewood Rch, Florida, United States
- Akero Clinical Study Site — Miami, Florida, United States
- Akero Clinical Study Site — New Port Richey, Florida, United States
- Akero Clinical Study Site — Ocoee, Florida, United States
- Akero Clinical Study Site — Port Orange, Florida, United States
- Akero Clinical Study Site — Sarasota, Florida, United States
- Akero Clinical Study Site — Baton Rouge, Louisiana, United States
- Akero Clinical Study Site — Marrero, Louisiana, United States
- Akero Clinical Study Site — Kansas City, Missouri, United States
- Akero Clinical Study Site — Berlin, New Jersey, United States
- Akero Clinical Study Site — Chattanooga, Tennessee, United States
- Akero Clinical Study Site — Cedar Park, Texas, United States
- Akero Clinical Study Site — Dallas, Texas, United States
- Akero Clinical Study Site — Edinburg, Texas, United States
- Akero Clinical Study Site — Fort Worth, Texas, United States
- Akero Clinical Study Site — San Antonio, Texas, United States
- Akero Clinical Study Site — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.